Chemistry of Life Processes Institute faculty member Richard Silverman (chemistry and molecular biosciences) has developed a new compound, OV329, that could provide many people relief from drug addiction. The story of OV329 recently received a write up in Science....
Thomas O’Halloran, Director of the Chemistry of Life Processes Institute and its Center for Developmental Therapeutics (CDT) is pleased to announce that William Sargent, PhD, former President of Lorex Pharmaceuticals and current member of Chicago Innovation Mentors,...
Biomedical engineer Vadim Backman develops more sensitive cancer diagnostics and more effective treatments Blue plastic bins of metal rods and black plastic posts line the basement walls. Drawers of a red metal tool chest are labeled wrenches, abrasives, string and...
We are saddened to share with you that CLP board member, Barbara Dyson, passed away March 11th. Barbara was a loyal supporter of CLP and a member of the Executive Advisory Board since 2007. Barbara was a founder and principal of Dyson, Dyson & Dunn, Inc., a...
Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population. Northwestern investigators have discovered why Huntington’s is so toxic to cancer cells...
